The FRAX® model recently developed by the WHO calculates 10-year probability of major osteoporotic and hip fracture, offering new basis for medical decision making and health economic analysis in osteoporosis (OP). [http://www.shef. ac.uk/FRAX/]. Patients' ideas regarding fracture risk and longevity might infl uence their perception of 10-year fracture risk data and compliance, and as a consequence, successful implementation of FRAX® based thresholds in everyday OP care. Our aim was to study whether FRAX® data differ from OP patients' and attendant especialists' self-estimations on fracture risk. We also assessed expectations on longliving which is a crucial point to perceive the 10-year farcture risk projection of FRAX® relevant. METHODS: In 2009 a cross-sectional survey was performed in 10 Hungarian rheumatology centres. Postmenopausal OP patients appearing on routine visit and switching to second line antiporotic drug were involved. Demographics, main clinical characteristics were registered. Patients' estimation on 10-year fracture risk and longliving were surveyed. Physicians' expectations on patients' perspectives were likely detected. FRAX® was calculated and matched with the estimations. RESULTS: 224 patients were involved, mean(SD): age 69.5(8.9)years, duration of OP care 6.7(5.1) years, lumbar Tsc-3.17(0.82), femoral Tsc-2.69(0.87), 133(59.4%) patients had OP fracture previously. Health status VAS was 59(17)mm. FRAX®-major OP fracture was 26(15.7)%, patients estimated 32.7(25.8)%, physicians marked 29.9(21.4)%. Results for hip fracture were: FRAX® 12.6(15.3)%, patients 26.7(25.3)%, physicians 21.5(19.1)% (P < 0.01). Patients' expected to live until age 82.4(8.2)years, physicians' estimation was nearly same (82.5, SD7 yrs). Less than 10-year survival was expected by 42,4% and 33.7%, respectively. CONCLUSIONS: Both patients and physicians overestimate fracture risk, especially for hip. Patients often expect to live shorter than the time-frame of the fracture risk projection. These aspects should be highly considered in health communication and also in the application of the FRAX® method in clinical practice.
PMS55 ANALYSIS ON THE POSSIBLE ASSOCIATION BETWEEN RHEUMATOID ARTHIRITIS AND DIABETES MELLITUS TYPE 2
Laires P 1 , Fonseca JE 1 , Garcia EB 2 1 Faculty of Medicine, University of Lisbon, Lisbon, Portugal; 2 BioEPI, Clinical and Translational Research Center, Lisbon, Portugal OBJECTIVES: Rheumatoid Arthritis (RA), a chronic infl ammatory disease, may predispose to the development of Type 2 Diabetes Mellitus (T2DM). We aimed to compare incidence rates of T2DM in RA versus non-RA populations and study the infl uencing factors. METHODS: The study population consisted of participants in the National Data Bank for Rheumatic Diseases (NDB), where patients with rheumatologic disorders completed semiannual questionnaires, from 1998 through 2008. Osteoarthritis (OA) patients were used as controls. T2DM was determined based on self-reports of disease and on the use of hypoglycemic medication. The association between RA and T2DM was investigated using COX logistic regressions adjusted for relevant clinical and demographic covariates. RESULTS: A total of 14,481 participants diagnosed with RA (79.5% female; mean age 58.1 years) and 3,441 participants diagnosed with OA (84.5% female; mean age 63.6 years) were followed during 69,943 person-years. RA subjects had lower Body Mass Index (BMI) and less major comorbidities than controls. In patients with RA the T2DM incidence rate was 10 per 1000 person-years, while the incidence rate for OA was 15 per 1000 person-years. Both rates are superior to most estimates calculated among the US population. However, the covariate-adjusted risk of T2DM in patients with RA versus OA was not signifi cant (HR = 0.94; 95% CI: 0.79-1.12, p = NS). Male gender, age, BMI, non-caucasian ethnicity, major comorbidities, low education level and prednisone intake were signifi cantly associated with the incidence of T2DM. Some RA drugs had a clear protective role on TDM2, mainly methotrexate (19% risk reduction; p = 0.022) and hydroxicloroquine (47% risk reduction; P < 0.001). CONCLUSIONS: RA per se is not associated with increased risk of T2DM. Both RA and OA are associated with known TDM2 risk factors, such as BMI and some comorbidities, increasing the incidence rates of TDM2. Some drugs for RA treatment have a signifi cant protective effect on the TDM2 risk. National University of Singapore, Singapore; 2 Singapore General Hospital, Singapore OBJECTIVES: Total knee replacement (TKR) is a commonly used surgical procedure for patients with severe joint damage caused by arthritis; however, there remain diffi culties in establishing criteria to defi ne the optimal timing for TKR. The aim of this study was to identify the preoperative threshold HRQoL scores that were associated with better postoperative outcomes and those associated with greater improvement. METHODS: Data were collected from 1715 patients undergoing TKR between 2001 and 2006. Patients were interviewed at baseline and at 6 months and 2 years after surgery. At all three interview sessions, patients were asked to complete the ShortForm (SF-36) and the Oxford Knee Score (OKS). As physical function and pain have been identifi ed as the key domains in osteoarthritis, the OKS and the physical functioning (PF) and bodily pain (BP) scales of the SF-36 were selected as the outcome measures of this study. Summary statistics were computed for preoperative, postoperative, and improvement in outcome scores. Visual inspection of the simple error bar charts were used to identify the threshold preoperative scores that were associated with better postoperative scores and those associated with more improvement. RESULTS: Patients with poorer preoperative HRQoL had worse postoperative outcomes but experienced greater improvement after TKR compared to those with better preoperative HRQoL. The highest postoperative PF scores are associated with a preoperative PF score of 50 points and above, whereas the baseline threshold OKS score was between 35 and 40 points. a baseline PF score of <30 points and an OKS score of >40 points are associated with the greatest improvement. No clear leveling off pattern was observed in the BP scores. CONCLUSIONS: PF and OKS threshold scores associated with optimal outcomes of TKR were identifi ed in this study. Future research is needed to examine the predictive value of the scores identifi ed in improving patients' post-operative outcomes. National University of Singapore, Singapore; 2 Singapore General Hospital, Singapore OBJECTIVES: To examine health-related quality of life (HRQoL) following total knee replacement (TKR) or unicompartmental knee arthroplasty (UKA). METHODS: Asian adult patients undergoing either TKR or UKA in a hospital of Singapore between 2001 and 2006 were interviewed before surgery and 6 and 24 months postoperatively to obtain demographic information and HRQoL scores using the ShortForm (SF-36) and the Oxford Knee Score (OKS). RESULTS: Data were collected from 2243, 1715, and 1113 patients at baseline, 6, and 24 months, respectively. TKR patients had a lower preoperative score than UKA patients on OKS and four subscales of the SF-36 (p < 0.01). Both TKR and UKA patients' OKS and SF-36 subscale scores improved six months postoperatively except in the general health domain. SF-36 role physical (RP) and bodily pain (BP) scores showed the most improvement (40.9 and 33.0 points in TKR and 36.9 and 31.4 points in UKA patients, respectively). The most substantial improvements between baseline and two years after surgery were in the physical domains of HRQoL (RP, BP, and physical functioning (PF)). In addition, in both groups, fi ve domains of SF-36 (RP, BP, PF, social functioning, and role limitations due to emotional problems) reached the proposed minimal clinically important difference of ten points. TKR patients' SF-36 and OKS scores were not signifi cantly different from those of UKA patients two year after surgery, except PF scores. Multiple regression analysis adjusting for sociodemographics showed that baseline scores were a signifi cant predictor of the postoperative scores of OKS and all SF-36 subscales (p < 0.01), whereas the type of surgery was not associated with the postoperative scores. CONCLUSIONS: Both TKR and UKA patients experienced signifi cant improvements in HRQoL, particularly in the RP and BP domains. After controlling for potential confounding variables, the type of surgery was not a signifi cant predictor of patients' postoperative HRQoL scores.
PMS56 DETERMINING THE OPTIMAL TIMING FOR TOTAL KNEE REPLACEMENT

PMS57 HEALTH-RELATED QUALITY OF LIFE AFTER TOTAL KNEE REPLACEMENT OR UNICOMPARTMENTAL KNEE ARTHROPLASTY IN AN URBAN ASIAN POPULATION
PMS58 CLINICAL OUTCOMES AND CHANGES IN QUALITY OF LIFE IN WOMEN WITH OSTEOPOROSIS TREATED WITH TERIPARATIDE: 36 MONTH RESULTS OF THE FRENCH PATIENTS PARTICIPATING IN THE EUROPEAN FORSTEO OBSERVATIONAL STUDY (EFOS)
Rajzbaum G 1 , Tcherny-Lessenot S 2 , liu-Leage S 2 , Gehchan N 2 , Barrett A 3 1 Saint Joseph Hospital, Paris, France; 2 Lilly France, Suresnes, France; 3 Eli Lilly & Company Ltd, Windlesham, Surrey, UK OBJECTIVES: To describe back pain, and HRQoL in postmenopausal women with osteoporosis treated with teriparatide (Forsteo®) in France. METHODS: European, prospective, observational study of 36 months duration (18-month active treatment phase and 18-month post-treatment follow up) in postmenopausal women with osteoporosis who initiated teriparatide. HRQoL measured by EQ-5D and back pain measured by a Visual Analogue Scale (VAS) and a questionnaire were collected at each follow-up visit. RESULTS: Among 309 patients enrolled in France (18.8% of the total EFOS cohort), 290 (94.5%) had any follow-up data, and 201 (65.0%) completed the last post-treatment visit. At baseline, patients were 73.8 (7.4) years old (mean (SD)),
